These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18689009)

  • 21. [Influence of cardiopulmonary bypass on cognitive functions in patients with ischemic heart disease].
    Buziashvili IuI; Ambat'ello SG; Aleksakhina IuA; Pashchenkov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):30-5. PubMed ID: 15704480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute treatment of stroke. PASS group. Piracetam Acute Stroke Study.
    De Deyn PP; Orgogozo JM; De Reuck J
    Lancet; 1998 Jul; 352(9124):326. PubMed ID: 9690444
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel use of modafinal to treat severe physical and cognitive impairment post-stroke.
    Geffen S; Shum K; Tan HM
    Intern Med J; 2013 Mar; 43(3):338. PubMed ID: 23441663
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of acatinol memantine in mild cognitive disorder].
    Levin OS; Iunishchenko NA; Dudarova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuropsychological and neuroimaging aspects of chronic cerebrovascular insufficiency in terms of structural and functional model of human brain].
    Chelysheva IA; Nagornyĭ NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):65-9. PubMed ID: 15704488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy].
    Bekuzarova MR; Burd GS; Kolesnikova TI; Iasamanova AN; Kabanov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):35-8. PubMed ID: 11517473
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening of vascular cognitive impairment on a Hungarian cohort.
    Szatmári S; Fekete I; Csiba L; Kollár J; Sikula J; Bereczki D
    Psychiatry Clin Neurosci; 1999 Feb; 53(1):39-43. PubMed ID: 10201282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Piracetam on Friedreich Ataxia.
    Elmal AD; Gündüz A; Uzun N; Apaydn H; Kzltan G
    Clin Neuropharmacol; 2016; 39(3):159-60. PubMed ID: 27171570
    [No Abstract]   [Full Text] [Related]  

  • 29. [Importance of vascular factors for cognitive rehabilitation in Parkinson's disease patients].
    Slobodin TN
    Lik Sprava; 2012; (7):176-9. PubMed ID: 23350146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiac disorders and cognitive impairment in patients with chronic cerebral ischemia].
    Semushkina EG; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):9-13. PubMed ID: 23528575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piracetam in the treatment of acute stroke.
    Orgogozo JM
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular risk factors and cognitive performance in patients 50 to 65 years-old].
    Miralbell J; Soriano JJ; López-Cancio E; Arenillas JF; Dorado L; Barrios M; Cáceres C; Alzamora MT; Torán P; Pera G; Dávalos A; Mataró M
    Neurologia; 2010 Sep; 25(7):422-9. PubMed ID: 20964988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of omaron in patients with post-stroke cognitive disorders].
    Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease.
    Sławek J; Wieczorek D; Derejko M; Dubaniewicz M; Brockhuis B; Sitek E; Wilczewska L; Roszmann A; Lass P
    Neurol Neurochir Pol; 2008; 42(6):505-12. PubMed ID: 19235103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
    Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vascular cognitive impairment in young patients].
    Dolgova IN; Starodubtsev AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):14-6. PubMed ID: 21510448
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
    Stephens S; Kenny RA; Rowan E; Allan L; Kalaria RN; Bradbury M; Ballard CG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1053-7. PubMed ID: 15481073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical features and neuropsychological profile in vascular parkinsonism.
    Benítez-Rivero S; Lama MJ; Huertas-Fernández I; Alvarez de Toledo P; Cáceres-Redondo MT; Martín-Rodríguez JF; Carrillo F; Carballo M; Palomar FJ; Mir P
    J Neurol Sci; 2014 Oct; 345(1-2):193-7. PubMed ID: 25108818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.